(Updated - May 10, 2024 6:46 AM EDT)

Mizuho analyst Vamil Divan lowered the price target on Revance Therapeutic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE